Vizsgálati helyszín
Kalispell Medical Oncology
Kalispell, Montana 59901, Egyesült ÁllamokMég nincs intézményhez kötve
- 12futó vizsgálat
- 6lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 18 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis13 vizsgálat
- 2. fázis5 vizsgálat
- Állapot
- Fut, nem toboroz12 vizsgálat
- Lezárult6 vizsgálat
- Fő szponzor
- National Cancer Institute (NCI)16 vizsgálat
- Eastern Cooperative Oncology Group1 vizsgálat
- SWOG Cancer Research Network1 vizsgálat
Futó vizsgálatok
Fut, nem toboroz
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
NCT01415752· 2. fázis· Eastern Cooperative Oncology Group· Forrás
Fut, nem toboroz
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
NCT01575548· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
NCT01169337· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
NCT01081262· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Dinaciclib in Treating Patients With Stage IV Melanoma
NCT00937937· 2. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
NCT00843882· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
NCT00658814· 2. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT00588770· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
NCT00644228· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT00602641· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
NCT00569127· 3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
NCT00070499· 2. fázis· National Cancer Institute (NCI)· Forrás
Hibát jelzek